Table 4.

Adverse drug reactions of the patient with confirmed COVID‐19

	FVP group (n = 32)	LPV/RTV group (n = 32)	p
Any	8 (25.0)	10 (32.3)	0.585
Gastrointestinal disorders	4 (12.5)	4 (12.9)	0.999
Abnormal liver function tests	0 (0.0)	1 (3.1)	0.999
Blood pressure increase	0 (0.0)	0 (0.0)	0.999
Bradycardia	1 (3.1)	0 (0.0)	0.999
Serum creatinine elevation	0 (0.0)	2 (7.1)	0.214
Leukopenia	4 (16.0)	3 (10.0)	0.689
Hematuria	0 (0.0)	0 (0.0)	0.999
Rash	0 (0.0)	0 (0.0)	0.999

Note: Values were expressed as n (%).

Data were collected within 7 days of randomization.

Comparison between groups was performed using Fisher's exact test.